HC Wainwright & Co. Reiterates Buy on Chimerix, Maintains $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on Chimerix (NASDAQ:CMRX) and maintained an $11 price target.
August 16, 2023 | 4:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Chimerix's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $11.
The reiteration of a 'Buy' rating and maintained price target by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. This could potentially lead to increased investor confidence and a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100